Tm Bioscience to Supply St. Joseph's Hospital with Tag-It™ Reagents
News Feb 16, 2006
"We selected Tm's Tag-It™ platform because we were impressed by its performance and flexibility. Tm's technology has allowed us to develop an assay testing for numerous CF associated mutations at once in a single well, an extremely time-efficient and cost-effective solution," said John Stone, Director of Laboratory Services at St. Joseph's Hospital.
"Because the platform is open and flexible, we ultimately anticipate providing our patients with a broader menu of important genetic tests using Tm reagents."
"We look forward to working with St. Joseph's Hospital to provide leading edge medical laboratory services for the state of Arizona," said Greg Hines, President and CEO of Tm Bioscience.
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut FloraNews
An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018